Conjoined Twins From Mali Given New Lease of Life at Sidra Medicine, Qatar

Food and Healthcare Press Releases Thursday October 11, 2018 08:00
DOHA, Qatar--11 Oct--PRNewswire/InfoQuest

Doctors at Qatar's first specialist women's and children's hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for the successful treatment and care of complex pediatric diseases in the region.

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8422651-conjoined-twins-find-new-lease-on-life/

The twins were conjoined at the liver and lower sternum - considered one of the riskier types of fusion, as each baby needs a fully functional liver of their own without compromising the other. Globally, conjoined twins occur once in about every 200,000 births. Omphalopagus twins, those who are connected at the belly and liver, are some of the most complex to separate.

Led by Dr. Mansour Ali, Chair of the Department of Pediatric Surgery and Dr. Abdalla Zarroug, Division Chief of Pediatric General and Thoracic Surgery, the four-month-old male twins were separated by a team of 10 surgeons and anesthesiologists, during a nine-hour procedure.

"By successfully separating conjoined twins, one of the most complex surgical procedures there is, we are proud to showcase the calibre of our multidisciplinary teams just a year since we opened our inpatient facility. The surgery is both a milestone for the hospital and healthcare in Qatar," said Dr. Mansour.

Less than 10 days after separation, Hamad and Tamim are recovering and expected to live normal, independent lives.

"Combined with access to the latest technology to support pre-surgical planning and delivery, we have the advantage of having some of the world's top pediatric specialists in general and thoracic surgery, urology, craniofacial, plastics, anesthesiology and robotic surgery. The fact that we are able to use these resources to offer pediatric surgical services that did not exist in the region before, is the reason we are here," said Dr. Zarroug.

The surgery was planned and rehearsed for months with a full complement of over 150 medical and support staff undergoing over 30 hours of simulation to minimize the risks and improve patient outcomes. Sidra Medicine's state-of-the-art 3D printing technology helped create a model of the boys' abdomen and liver to assist with pre-surgical planning.

The father said: "We tried to explore international options for surgery until we found out about Sidra Medicine. We are immensely grateful to the Government of Qatar, Hamad Medical Corporation and Sidra Medicine for their tireless efforts to save the lives of our boys."

Farhana Habib
Public Relations
t. +974-4404-2176
m. +974-7478-4648
fcoelho@sidra.org
Photo: https://mma.prnewswire.com/media/766865/Sidra_Medicine.jpg
Source: Sidra Medicine

Latest Press Release

Kemin Launches New Vision and Logo for the Future

Global ingredient manufacturer sets sights on sustainably transforming 80 percent of the world by 2042 Today Kemin Industries, a global ingredient manufacturer, unveiled its new global vision and logo to align the company strategically for 2042 and...

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The...

Zeus Expands Portfolio with New Polyimide Family of Products

Products Include PI Tubing, PI Coated Wire, PI Glide(TM) Tubing, and PI Glide(TM) Coated Wire Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a new polyimide...

SCG partners up with Frances Institut Pasteur to combat dengue with innovations to reduce mosquito breeding

Dr. Suracha Udomsak, Chief Technology Officer, on behalf of Chemicals Business, SCG, and Dr. Anavaj Sakuntabhai, Coordinator of the Defeat Dengue Program, Head of Structure, Functional Genetics of Infectious Diseases, representing Institut Pasteur,...

เอสซีจี จับมือ สถาบันปาสเตอร์ ฝรั่งเศส หยุดการระบาดของโรคไข้เลือดออกด้วยการพัฒนานวัตกรรมลดการแพร่พันธุ์ยุงลาย

ธุรกิจเคมิคอลส์ เอสซีจี โดย ดร.สุรชา อุดมศักดิ์ Chief Technology Officer และ สถาบันปาสเตอร์ ประเทศฝรั่งเศส (Institut Pasteur) โดย ดร. อนวัช ศกุนตาภัย Coordinator of the Defeat Dengue Program, Head of Structure, Functional Genetics of Infectious Diseases,...

Related Topics